OrSense Ltd.'s Non-Invasive Hemoglobin Monitor Offers for the First Time the Ability to Detect Hemorrhage Accurately and Within Minutes

NES ZIONA, Israel--(BUSINESS WIRE)--OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented in an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in Chicago, results showing that its NBM 200MP, a non-invasive Hemoglobin (Hb) measurement system, detects hemorrhage accurately and within minutes. The sensitivity of the NBM 200MP was 96% compared to an invasive, "golden standard" measurement, and the non-invasive monitor detected hemorrhage in less than 4 minutes.